Prognostic Value of Biomarkers in Polyneuropathy.
ConditionPolyneuropathies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRigshospitalet, Denmark
Biomarkers for prognosis of patients with polyneuropathy.
Minimum 18 years old.
Diagnosed with polyneuropathy, confirmed by nerve conduction study.
Can read and understand Danish.
Inability to perform physical tests due to comorbidity not associated to the patient's polyneuropathy.